T2 Biosystems Inc Рыночная капитализация

Что обозначает Рыночная капитализация в T2 Biosystems Inc?

Рыночная капитализация T2 Biosystems Inc является $10.39M

Какое определение для Рыночная капитализация?

Рыночная капитализация - это рыночная стоимость в тот момент времени, когда акции, находящиеся в обращении публичной компании, равна цене акций в тот отрезок времени, умноженной на количество акций в обращении .

As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.

Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.

The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.

Что делает T2 Biosystems Inc?

t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www

Компании с рыночная капитализация похож на T2 Biosystems Inc

  • Global Vectra Helicorp имеет Рыночная капитализация из $10.38M
  • Willow Biosciences имеет Рыночная капитализация из $10.38M
  • MJ имеет Рыночная капитализация из $10.38M
  • FinTech Chain имеет Рыночная капитализация из $10.38M
  • mVISE AG имеет Рыночная капитализация из $10.39M
  • VerifyMe имеет Рыночная капитализация из $10.39M
  • T2 Biosystems Inc имеет Рыночная капитализация из $10.39M
  • Prime Intelligence Solutions имеет Рыночная капитализация из $10.40M
  • Titon Plc имеет Рыночная капитализация из $10.40M
  • Akar Auto Industries имеет Рыночная капитализация из $10.40M
  • Inditrade Capital имеет Рыночная капитализация из $10.40M
  • HKBridge имеет Рыночная капитализация из $10.41M
  • Chilean Metals имеет Рыночная капитализация из $10.41M